2024-511851-16-00招募中1 期
A phase 1 study to evaluate the dose, safety and tolerability of a radionuclide therapy (Radspherin®) in patients with platinum sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma with peritoneal carcinomatosis following complete surgical resection
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Information Desk
Scientific
Oncoinvent ASA
研究点 (3)
Loading locations...
相似试验
已完成
1 期
A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumors2022-500902-16-00Philogen S.p.A., Philogen S.p.A.20
招募中
1 期
Phase 1 study to examine the safety and dose-dependent effect of rapamycin topical medicine on perspiration in healthy volunteershyperhidrosisJPRN-UMIN000016525Department of Dermatology Graduate School of Medicine, Osaka University12
已完成
不适用
A phase I study to evaluate the safety and pharmacokinetics of TRN501 in healthy adult Japanese male volunteers.Parkinson's diseasejRCT2031230689SNLD, Ltd.72
招募中
不适用
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects With Advanced Solid TumorsjRCT2031240279GlaxoSmithKline K.K.10
招募中
1 期
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid TumorsNCT06954077Sichuan Baili Pharmaceutical Co., Ltd.45